Loading…

Antimicrobial, Antioxidant, and Cytotoxic Activities of the Essential Oil of Tarchonanthus camphoratus

The leaf essential oil of Tarchonanthuscamphoratus(Asteraceae) was obtained by hydrodistillation and analyzed by GC-MS. Fifty-six components were characterized, representing 94.2% of the total oil with oxygenated monoterpenes (48.3%) and oxygenated sesquiterpenes (32.7%) as the major groups. The pri...

Full description

Saved in:
Bibliographic Details
Published in:Natural product communications 2013-05, Vol.8 (5)
Main Authors: Ali, Nasser A. Awadh, Al-Fatimi, Mohamed A., Crouch, Rebecca A., Denkert, Annika, Setzer, William N., Wessjohann, Ludger
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The leaf essential oil of Tarchonanthuscamphoratus(Asteraceae) was obtained by hydrodistillation and analyzed by GC-MS. Fifty-six components were characterized, representing 94.2% of the total oil with oxygenated monoterpenes (48.3%) and oxygenated sesquiterpenes (32.7%) as the major groups. The principal constituents were identified as endo-fenchol (21.2%), trans-pinene hydrate (8.8%), caryophyllene oxide (7.5%), α-terpineol (6.4%), τ-cadinol (6.4%), and α-cadinol (5.2%). The essential oil was evaluated for its antimicrobial activity using a disc diffusion assay resulting in the moderate inhibition of a number of common human pathogenic bacteria, including methicillin-resistant Staphylococcus aureus(MRSA) and the yeast Candida albicans. The inhibition zones varied from 10 to 14mm/disc. Furthermore, the antioxidant capacity of the essential oil was examined using an in vitroradical scavenging activity test. The T. camphoratus essential oil scavenged 1,1-diphenyl-2-picrylhydrazyl radical (DPPH), resulting in an IC50value of 5.6 mg/mL. At concentrations of 100 and 50μg/mL, the oil showed cytotoxic activity, with growth inhibition of 59.1% (±4.2), and 16.2% (±8.7) against HT29 tumor cells (human colonic adenocarcinoma cells), respectively(IC50 = 84.7 ± 7.5 μg/mL).
ISSN:1934-578X
1555-9475
DOI:10.1177/1934578X1300800534